GSK sees shingles vaccine sales rising, as free cash flow concerns weigh 0 01.05.2019 21:07 BigNewsNetwork.com GSK sees shingles vaccine sales rising, as free cash flow concerns weigh Reuters GlaxoSmithKline forecast on Wednesday that 2019 sales of its shingles vaccine would be more than 1 billion pounds ($1. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
